Treatment with this Mab is well tolerated with acceptable immediate adverse reactions. Candida infections are a problem, possibly due to immunosuppression. A significant proportion of patients showed improvement of GvHD, and 63% survive 1 year later. We have not as yet observed the occurrence of malignant lymphomas.
|Number of pages||2|
|Publication status||Published - 1985|
ASJC Scopus subject areas